A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations

NCT00942604 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

203

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratoses

Interventions

DRUG: PEP005 (ingenol mebutate) Gel
DRUG: Vehicle gel

Sponsor

Peplin